RxElite, Inc.
RXEI
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Revenue | 10.44M | 7.93M | 5.66M | 2.81M | 1.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.44M | 7.93M | 5.66M | 2.81M | 1.84M |
| Cost of Revenue | 9.44M | 7.11M | 5.17M | 2.67M | 1.51M |
| Gross Profit | 997.00K | 821.00K | 493.60K | 143.90K | 330.40K |
| SG&A Expenses | 12.75M | 11.78M | 10.16M | 9.08M | 6.08M |
| Depreciation & Amortization | 987.70K | 720.40K | 469.10K | 197.10K | 208.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.97M | 21.31M | 18.29M | 15.09M | 10.74M |
| Operating Income | -13.53M | -13.38M | -12.63M | -12.28M | -8.91M |
| Income Before Tax | -29.23M | -21.43M | -22.00M | -17.17M | -14.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.23 | -21.43 | -22.00 | -17.17 | -14.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.23M | -21.43M | -22.00M | -17.17M | -14.41M |
| EBIT | -13.53M | -13.38M | -12.63M | -12.28M | -8.91M |
| EBITDA | -11.55M | -11.99M | -11.76M | -11.84M | -8.64M |
| EPS Basic | -0.26 | -0.21 | -0.31 | -0.31 | -0.33 |
| Normalized Basic EPS | -0.14 | -0.14 | -0.13 | -0.13 | -0.13 |
| EPS Diluted | -0.26 | -0.21 | -0.31 | -0.31 | -0.33 |
| Normalized Diluted EPS | -0.14 | -0.14 | -0.13 | -0.13 | -0.13 |
| Average Basic Shares Outstanding | 436.48M | 398.74M | 327.32M | 249.11M | 189.19M |
| Average Diluted Shares Outstanding | 436.48M | 398.74M | 327.32M | 249.11M | 189.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |